The global nasogastric tube market size is expected to reach USD 754.5 billion by 2030, expanding at 5.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The major factors that fuel the market growth are the rising penetration of chronic conditions such as CVD, bleeding disorders, dysphagia, and others. A growing number of preterm births and an increasing geriatric population further boost the market growth.
The geriatric population inhibits higher chances of comorbid conditions that lead them to develop malnutrition. In such situations, nasogastric tubes are highly useful. As per the data from the CDC, in 2021, preterm birth affected about one of every ten infants born in the U.S. The percentage of preterm cases increased from 10.1% in 2021 to 10.5% in 2022. Similarly, according to the WHO, people aged 60 and above increased from 900 million in 2015 to 2,000 million in 2050.
Furthermore, key players worldwide are focusing on various strategic initiatives such as launching advanced products, expansion, and mergers & acquisitions to expand their dominance in the market. For instance, in May 2021, QMD expanded its enteral feeding portfolio by launching a new Degania line of Bi-Port and Single-Port Feeding Tubes for nasogastric feeding.
Unlike other markets, COVID-19 didn’t negatively impact the industry as there was a significant rise in the number of hospitalizations, which further increased the demand for nasogastric tubes for critically ill patients. However, factors such as delayed development of technologically advanced products, and increasing cases of side effects like skin irritation, tube perforation, tube dislocation, retching, and gagging are projected to hamper the market growth over the forecast period.
Request a free sample copy or view report summary: Nasogastric Tube Market Report
In 2022, the adult segment held the largest share of 36.9%, and the geriatric population is projected to register the fastest CAGR growth over the forecast period. An increased aging population and a growing number of chronic conditions are positively impacting the industry's growth
In 2022, the dysphagia segment dominated the market growth with a revenue share of 20.5%. However, the others segment is projected to showcase the fastest CAGR over the forecast period due to rising cases of cancer, stroke, and others
Based on type, the small-bore feeding tubes segment held the largest revenue share of 61.08% in 2022 and is also further expected to showcase the fastest CAGR over the forecast period due to the launch of technologically advanced products and effectiveness
Based on end-use, hospitals & nursing homes held the largest market share of about 59.7% in 2022. The home care segment is projected to grow at the fastest CAGR
In 2022North America dominated the market in 2022 with a revenue share of 37.5%. The major factors that attribute the industry growth are the easy availability of technologically advanced products and high awareness among patients about nasogastric tubes
Grand View Research has segmented the global nasogastric tube market based on patient type, indication, type, end-user, and region.
Nasogastric Tube Patient Type Outlook (Revenue, USD Million, 2018 - 2030)
Adult
Pediatric
Geriatric
Nasogastric Tube Indication Outlook (Revenue, USD Million, 2018 - 2030)
Stomach Cancer
Esophageal Cancer
IBD
Chronic Kidney Disease
Dysphagia
Others
Nasogastric Tube Type Outlook (Revenue, USD Million, 2018 - 2030)
Small-bore feeding tubes
Large-bore feeding tubes
Nasogastric Tube End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Nursing Homes
Home Care
Nasogastric Tube Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain `
Italy
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Nasogastric Tube Market
BD
QMD
Angiplast Pvt. Ltd.
Securmed
Vygon
Medtronic
Andersen Products Inc.
Cardinal Health
Poly Medicure Limited
Baihe Medical
"The quality of research they have done for us has been excellent..."